Prosthetic valve endocarditis caused by Brucella melitensis. A report of four cases successfully treated with tetracycline, streptomycin, and sulfamethoxazole and trimethoprim plus valve replacement
- 1 June 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 147 (6) , 1141-1143
- https://doi.org/10.1001/archinte.147.6.1141
Abstract
Optimal treatment of prosthetic valve endocarditis due to Brucella melitensis is unknown. The presence of ring abscess makes extensive surgical debridement and valve replacement essential steps of management. Antimicrobial therapy with tetracycline hydrochloride plus streptomycin sulfate or sulfamethoxazole and trimethoprim can achieve the sterilization of infected cardiac tissue. Late bland periprosthetic leaks occur frequently. Reoperation can be safely performed after a period of antimicrobial therapy. Prolonged treatment with doxycycline hyclate seems advisable.This publication has 8 references indexed in Scilit:
- Treatment of Streptomycin-Susceptible and Streptomycin-Resistant Enterococcal EndocarditisAnnals of Internal Medicine, 1984
- Brucella mellitensis Endocarditis on a Porcine Heterograft BioprosthesisChest, 1981
- 2-mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosisJournal of Clinical Microbiology, 1980
- Successful treatment of brucella melitensis endocarditisThe American Journal of Medicine, 1978
- Operative treatment of active endocarditisThe Journal of Thoracic and Cardiovascular Surgery, 1976
- SYNERGISTIC ACTION OF STREPTOMYCIN WITH OTHER ANTIBIOTICS ON INTRACELLULARBRUCELLA ABORTUSIN VITROJournal of Bacteriology, 1962
- BRUCELLOSIS AND HEART DISEASE .2. FATAL BRUCELLOSIS - A REVIEW OF THE LITERATURE AND REPORT OF NEW CASES1960
- Brucella abortus EndocarditisCirculation, 1957